-1 -1 TREATMENT OF APOLIPOPROTEIN-A1 RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO APOLIPOPROTEINA1

摘要

Oligonucleotide compounds modulate the expression and / or function of apolipoprotein (ApoA1) polynucleotides and their encoded products. Methods for treating diseases associated with apolipoprotein A1 (ApoA1) include administering to the patient one or more oligonucleotide compounds designed to inhibit the Apo-A1 natural antisense transcript.